He said he believes genomic medicine is at a critical inflection point. “We have a lot of information. We need to exploit it to intervene, not at the most costly advanced stages of symptoms, but at early pre-symptomatic stages where we can truly prevent diseases from manifesting.”
Dr. Reed Tuckson, senior vice president for consumer health and medical care advancement at UnitedHealth Group, said there's a lot of public and physician education work that needs to be done before anyone will be able to make good on Dr. Zerhouni's vision.